Marinus Pharmaceuticals has raised $21M in total funding. Latest round: Series C. Backed by Domain Associates, Rusnano MedInvest, Canaan Partners.
Marinus Pharmaceuticals has raised $21M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series C announced in January 2013. The round record for Marinus Pharmaceuticals runs through 2013; nothing later has been disclosed. Investors on record include Domain Associates, Rusnano MedInvest, Canaan Partners, Sofinnova Ventures, Foundation Medical Partners. 5 distinct backers are named across the disclosed rounds.
Totals shown for Marinus Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026